ASTER DM HEALTHCARE LTD Q4 RESULTS
Olympus Capital Asia divests 9% stake in Aster DM Healthcare for Rs 1,530 crore
According to bulk deal data from BSE, Olympus Capital Asia Investments sold 4.50 crore shares, equivalent to a 9% stake in Aster DM Healthcare, in two tranches. The shares were sold within the price range of Rs 340 to Rs 340.13 each, totalling Rs 1,530.08 crore.
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
Apollo Hospitals shares rally 3% after reporting Rs 258 crore profit. Should you buy, sell or hold?
Apollo Hospitals Share Price: Apollo Hospitals shares surged by 3.4% during Friday's early trading session, reaching a peak of Rs 5,955. This uptick followed the company's announcement of a significant 77% year-on-year (YoY) increase in its net profit.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%
Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.
Q4 results today: Apollo Hospitals among 895 companies to announce earnings on Thursday
Fourth quarter earnings season is wrapping up with 895 companies reporting results on Thursday. Investors keenly await Apollo Hospitals' results, expecting robust growth driven by improved ARPOB and HealthCo operations. Analysts predict up to a 68% YoY increase in net profit, with sales expected to rise by 13%.
- Go To Page 1
Emami Q4 Results: Profit rises 4% to 146.75 crore, revenue up 7%
Homegrown FMCG major Emami Ltd on Wednesday reported an increase of 3.62 per cent in its Profit After Tax (PAT) to Rs 146.75 crore for the fourth quarter that ended on March 31, 2024.
3M India Q4 Results: 'Post-it' maker posts profit rise; shares surge
3M INDIA-RESULTS/'Post-it' maker 3M India posts Q4 profit rise; shares surge
IRCTC, ABFRL, JSW Holdings among 453 companies declaring Q4 results on Tuesday
453 companies, including IRCTC and Aditya Birla Fashion, are set to declare Q4 results. Most companies report profits, boosting Nifty and Sensex to new highs. Market bullish ahead of Lok Sabha elections.
Aster to invest Rs 250 crore in CMI Hospital, to upscale to 850 beds
Aster DM Healthcare announced a major expansion plan for Aster CMI Hospital in Bengaluru, increasing its bed capacity from 500 to 850 beds with a 300,000 sq ft infrastructure expansion. With a total of 1602 beds, the company strengthens its presence in Bengaluru. The Rs. 250 crore investment aims to upgrade facilities by fiscal year 2027, reinforcing their commitment to quality healthcare and strategic growth.
Q4 results this week: Tata Steel, LIC, IRCTC, Apollo Hospitals Enterprise, and Bharat Dynamics
Several companies, including Tata Steel, LIC, and IRCTC, will release their March quarter report cards this week.
Q4 results today: NTPC, Hindalco among 257 companies to announce earnings on Friday
257 companies, including NTPC, Hindalco, and Novelis, to announce Q4 earnings. Hindalco may see muted revenues but higher profitability. NTPC expected to have a decline in PAT compared to Q4FY23.
Fortis Healthcare Q4 Results: Net profit jumps 47% YoY to Rs 203 crore
Fortis Healthcare Ltd on Thursday reported a 46.88 per cent increase in consolidated net profit at Rs 203.14 crore in the fourth quarter ended March 2024 on the back of higher revenue from its core business.
Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday
181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.
Max Healthcare Institute Q4 Results: PAT down 3% YoY to Rs 311 crore
Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement.
Max Healthcare Q4 Results: Net profit drops 3% YoY to Rs 311 crore
Max Healthcare's Q4FY24 net profit dips 3% YoY to Rs 311 crore, attributed to lower effective tax rate in Q4FY23 and new unit losses. Gross revenue rises 15% YoY to Rs 1,890 crore.
Q4 results today: Sun Pharma, Nykaa, Paytm among 162 companies to declare earnings on Wednesday
162 companies to report Q4 earnings on Wednesday. Nykaa expects 24% BPC and Fashion GMV growth, while Paytm faces a revenue decline from RBI actions. Analysts also predict pressure from discounting and lower advertising income.
Metropolis Healthcare Q4 Results: Net profit rises 8% to Rs 36 crore
The diagnostic chain reported Rs 33.5 crore net profit in the corresponding quarter of the previous year. Revenue from operations grew by 11% YoY to Rs 313 crore.
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC
ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi's lab will be releasing their March quarter report cards this week.
Mankind Pharma Q4 Results: Net profit jumps 62% YoY to Rs 477 crore
Mankind Pharma on Wednesday reported 62% year-on-year (YoY) jump in net profit to Rs 477 crore in Q4FY24 led by strong domestic formulation sales and one-off US export opportunities.
Cipla shares surge over 6% post Q4 results. Should you buy or sell?
Meanwhile, EBITDA for the quarter under review increased 13% YoY to Rs 1,316 crore as against 1166 crore in the last year period.
Happiest Minds Tech Q4 Results: Profit jumps 25%, revenues up 10%
Happiest Minds Tech Q4 Results: For full year, the Bengaluru-headquartered firm’s profit rose 7.5% to Rs 248.39 crore from Rs 230.99 crore in FY23. Revenues increased 13.7% to Rs 1624.66 crore from Rs 1,429.29 crore last year.
Deals, hiring show HCL Tech can tap expected IT bounce
Revenue in the major markets of the US and Europe grew sequentially by 4.2% and 2.3%, respectively, while major business verticals also showed higher revenue. But what sets HCLTech apart from peers is the fact that it continued to add headcount during the quarter.
Wipro Q4 Results Preview: Muted show likely once again, all eyes on new CEO’s growth roadmap
Wipro Q4 Results Preview: The company is projected to see its consolidated revenue remain stagnant compared to the previous quarter and decrease by 4.3% year-on-year (YoY) to Rs 22,185 crore, based on the average estimates provided by 10 brokerage firms.
Technical Breakout Stocks: How to trade Aster DM Healthcare, Thermax and Exide Industries on Tuesday?
Sectorally, buying was seen in oil & gas and energy while selling was seen in IT, banks, capital goods, and power indices.
Stocks in news: TCS, Anand Rathi, Aster DM, Bharti Hexacom, Varun Beverages
IT bellwether TCS reported better than expected numbers for the fourth quarter ended March as its profit rose 9% year-on-year to Rs 12,434 crore. Revenue from operations, meanwhile, jumped 3.5% year-on-year.
Olympus Capital Asia divests 9.8% stake in Aster DM Healthcare for Rs 1,978 cr
According to the bulk deal data available with the BSE, more than 4.42 crore equity shares of Aster DM Healthcare were sold by Olympus Capital Asia Investments and 45.59 lakh shares by Olympus ACF Pte Ltd of the company. In a separate deal, Capital Group acquired shares of Aditya Vision, a financial services company, for Rs 95 crore.
Load More